Can amlodipine reduce dystolic bp

Yes, amlodipine does reduce diastolic blood pressure. It is a dihydropyridine calcium channel blocker that causes peripheral vasodilation by blocking L-type calcium channels in vascular smooth muscle, reducing both systolic and diastolic BP. In clinical use, diastolic reductions of roughly 8-12 mmHg are typical, though the effect on systolic BP tends to be proportionally larger.
Searching sources...
Reading File
Searching PubMed

amlodipine diastolic blood pressure reduction

Now let me search the textbook library for detailed pharmacology content on amlodipine:
Finding Sources
Finding Sources
Reading File
I now have solid textbook and clinical trial data to give a thorough answer. Here is the full response:

Amlodipine and Diastolic Blood Pressure

Yes - amlodipine reliably reduces diastolic BP, though its effect on systolic BP is often proportionally larger.

Mechanism of Action

Amlodipine is a long-acting dihydropyridine calcium channel blocker (CCB). It blocks L-type voltage-gated Ca²⁺ channels in vascular smooth muscle, reducing intracellular calcium and causing peripheral arterial vasodilation. This lowers afterload and reduces both systolic and diastolic blood pressure.
Key pharmacodynamic points from Goodman & Gilman's (9th ed.):
  • Dihydropyridines like amlodipine exert their antihypertensive effect mainly through peripheral arterial vasodilation, not venous effects.
  • They have high vascular selectivity (vascular EC50 is ~5x lower than cardiac muscle), meaning the BP-lowering effect is predominantly vascular.
  • Amlodipine has minimal direct negative inotropic or chronotropic effects at antihypertensive doses.

Effect on Diastolic BP

EffectTypical Reduction
Systolic BP10-20 mmHg
Diastolic BP8-12 mmHg
  • Amlodipine reduces both systolic and diastolic BP, but in isolated systolic hypertension (common in the elderly), the diastolic reduction may be modest or even attenuated.
  • Its ultra-long half-life (~35-50 hours) provides smooth, sustained BP control over 24 hours, avoiding BP spikes and troughs.

Clinical Evidence

Several RCTs confirm diastolic BP reduction:
  1. Wang et al., 2021 (PMID 33135429) - In a double-blind RCT, amlodipine significantly reduced both clinic and ambulatory diastolic BP in hypertensive patients.
  2. Honda et al., 2023 (PMID 36737518) - Amlodipine reduced diastolic BP and improved endothelial function alongside blood pressure lowering.
  3. Rognstad et al., 2025 (PMID 40616336) - Pharmacokinetic variability in amlodipine serum concentrations correlated with varying degrees of BP reduction, including diastolic BP.

Important Clinical Notes

  • Isolated diastolic hypertension: Amlodipine is effective here too, though most guidelines (JNC, ESH) recommend CCBs as first-line agents for hypertension broadly.
  • Reflex tachycardia: As a dihydropyridine, amlodipine can cause mild reflex sympathetic activation; however, its slow onset and long half-life make this far less pronounced than with short-acting agents like immediate-release nifedipine.
  • Diastolic dysfunction (impaired ventricular relaxation): The effect of CCBs on diastolic ventricular function is complex - Goodman & Gilman notes reflex sympathetic stimulation and afterload reduction may actually improve the lusitropic state, partially offsetting any direct negative effect.
  • Combination therapy: Amlodipine is commonly combined with ARBs (e.g., candesartan or valsartan) for additional diastolic BP control, as shown in Hanna et al., 2024.

Bottom line: Amlodipine effectively reduces diastolic BP through sustained peripheral vasodilation. It is a first-line agent for hypertension and is particularly useful when both systolic and diastolic BP need to be lowered.
This is a shared conversation. Sign in to Orris to start your own chat.